# To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension

> **NCT03261375** · NA · COMPLETED · sponsor: **Shanghai Golden Leaf MedTec Co. Ltd** · enrollment: 205 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DEVICE:** Renal Artery Radiofrequency Ablation System (Generator and Catheter )
- **DRUG:** Antihypertensive Agents
- **DEVICE:** Sham Procedure

## Key facts

- **NCT ID:** NCT03261375
- **Lead sponsor:** Shanghai Golden Leaf MedTec Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-19
- **Primary completion:** 2022-12-26
- **Final completion:** 2022-12-26
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03261375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03261375, "To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03261375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*